Similar to the BRCA1/2 literature, individuals with a PV reported higher levels of testing-related concerns and cancer-specific distress, as well as higher uptake of prophylactic surgery in both affected and unaffected individuals compared to those with VUS or negative result. This evidence concerns the gene BRCA1 and cancer.